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Human T-lymphotropic virus type II (HTLV-II) prevalence is very low among the general U.S. population, intermediate
among American Indians, and high among injecting drug users and their sexual partners. However, the transmission
dynamics underlying this distribution are not well described. We obtained blood specimens from 493 blood donors found to
be seropositive for HTLV-II at blood centers in five U.S. cities. Nested polymerase chain reaction was used to amplify a
672-bp region of the HTLV-II long terminal repeat region, and restriction fragment length polymorphism (RFLP) analysis was
performed to classify each virus into subtypes as defined by Switzer et al. (1995, J. Virol. 69, 621–632). Associations between
RFLP subtype and other characteristics were analyzed using multivariable logistic regression. HTLV-II subtype a0 was
independently associated with age over 30 years (odds ratio (OR) 5 2.12, 95% confidence interval (CI) 1.13–3.99) and with
Black race/ethnicity (OR 5 2.00, 95% CI 1.10–3.65 versus Hispanic race/ethnicity). Conversely, HTLV-II RFLP subtypes b4 and
b5 were significantly more common among American Indian (OR 5 3.77, 95% CI 1.23–11.57) and Other race/ethnicity (OR 5
4.22, 95% CI 1.25–14.27, both versus Black race/ethnicity) and at the Oklahoma City blood center (OR 5 3.57, 95% CI
1.08–11.84 compared to Washington, DC/Baltimore). There may have been at least two transmission foci of HTLV-II in the
United States: a modest HTLV-II subtype a0 epidemic of unknown source in the 1960s and 1970s spread predominantly
among Black persons in several geographic areas and a smaller focus of HTLV-II subtypes b4/b5 among non-Black
individuals in Oklahoma and perhaps in other areas not examined by this study. © 2001 Academic PressINTRODUCTION
Human T-lymphotropic virus type II (HTLV-II) has re-
cently been found to be endemic among Amerindian
tribes in North, Central, and South America (Hjelle et al.,
1994; Reeves et al., 1990; Maloney et al., 1992) and
among pygmies and other people in Central Africa (Ges-
sain et al., 1995; Vandamme et al., 1998; Letourneur et al.,
1998). However, in North America and Europe, HTLV-II
prevalence is highest among injecting drug users (IDUs)
and their sexual partners, who probably represent an
epidemic focus of HTLV-II that has occurred over the
past 30 to 100 years (Khabbaz et al., 1992; Zella et al.,
1990; Salemi et al., 1996). Finally, former blood donors,
and by inference, the general population, show evidence
of a low-level HTLV-II epidemic in age cohorts affected
by the wider dissemination of drug injection and second-
ary sexual transmission that occurred in the 1960s and
1970s (Murphy et al., 1999b). From equilibrium in an
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90endemic population, HTLV-II probably became epidemic
among IDUs by the efficient new vector of needle sharing
and then spread via sexual transmission to a minority of
the general population. As such, it is a potentially useful
model of the transmission dynamics of other human
retroviruses including human immunodeficiency virus
(Slattery et al., 1999).
However, the data supporting this scenario are cir-
cumstantial and incomplete. In particular, the hypothesis
that HTLV-II spread from American Indians to IDUs is
based upon presumption rather than proof of transmis-
sion between these two population subgroups. Although
there is broad geographic proximity between IDU and
North American Indians and some evidence of sexual
contact between the two populations (Fenaughty et al.,
1998), there is no evidence that HTLV-II was actually
transmitted between the two groups. In addition, molec-
ular epidemiologic studies have demonstrated that most
IDUs are infected with HTLV-II restriction fragment length
polymorphism (RFLP) subtypes a0 and a3, whereas Am-
erindians are more likely to harbor RFLP subtypes b5, a5,
a6, and a7 (Switzer et al., 1995; Murphy et al., 1998). The
possibility that another endemic focus was the source for
the IDU epidemic of HTLV-II must be considered until a
definitive link between Amerindians and IDUs is demon-
strated.
More widespread molecular epidemiology data on the
91HTLV-II RFLP SUBTYPES IN THE UNITED STATESdistribution of HTLV-II subtypes in well-characterized
populations are needed to resolve these issues. Such
data may also be useful in efforts to calculate a “molec-
ular clock” for HTLV-II based upon the differential muta-
tion rate in samples of known infection dates (Salemi et
al., 1999a,b). We therefore extended our previous data
using a broader sample of HTLV-II-infected former blood
donors diagnosed in five cities in the United States
between 1988 and 1992 (Murphy et al., 1998, Murphy et
al., 1999a,b).
RESULTS
Study population and distribution of HTLV-II RFLP
subtypes
The study population consisted of 493 individuals from
five different cities, with demographic characteristics
shown in Table 1. Reflecting differences in donor base
and in HTLV-II seroprevalence among blood centers, the
number of HTLV-II-infected donors ranged from 35 in
Oklahoma City to 266 in Los Angeles. The median age of
the subjects was 41 (range 17 to 78) and almost three-
quarters of the subjects were female. Forty percent of
subjects were of Black race/ethnicity, followed by one-
quarter each of Caucasian and Hispanic race/ethnicity.
HTLV-II RFLP subtypes were classified according to
Switzer and Heneine (see Switzer et al., 1995). RFLP type
a0 was most commonly observed, with 358 (72.6%) of all
subjects classified in this subtype, followed by 45 (9.1%)
b4, 38 (7.7%) b5, 20 (4.1%) a3, 9 (1.8%) a5, 5 (1.0%) a2, 2
(0.4%) a6, 2 (0.4%) b1, and 1 (0.2%) each of subtypes a7
and b0. Seven specimens were classified into subtypes
T
Demographic Characteristics of the HTLV-II-In
Washington, DC
(n 5 80)
Number (%)
Detroit
(n 5 42)
Number (%)
L
N
Age
,30 6 (7.5) 2 (4.8)
30–39 33 (41.3) 16 (38.1)
40–49 27 (33.8) 8 (19.1)
501 14 (17.5) 16 (38.1)
Sex
Male 17 (21.3) 14 (33.3)
Female 63 (78.8) 28 (66.7)
Race/ethnicity
White 10 (12.5) 15 (35.7)
Black 68 (85.0) 26 (61.9)
Hispanic 1 (1.25) 0 (0)
Indian 0 (0) 0 (0)
Other 1 (1.25) 1 (2.4)
Note. Percentages may not add to 100 due to rounding.previously recognized by Murphy et al. (1998) as falling
outside the Switzer and Heneine classification, including3 (0.6%) bx, 3 (0.6%) by, and 1 (0.2%) bz (of which 2 bx, 1
by, and 1 bz specimens have previously been reported)
(Switzer et al., 1995). Five (1.0%) specimens representing
five potential new RFLP types could not be classified into
any previously reported RFLP subtype.
Demographic associations with HTLV-II subtypes—
All subjects
Since nearly three-quarters of subjects in the current
study were the U.S. IDU-associated RFLP type a0, we
first analyzed the demographic characteristics of this
RFLP type in comparison to that of all other subtypes
combined (Table 2 and Fig. 1). In the unadjusted analy-
sis, RFLP type a0 was more common among subjects
aged 30 years and older compared to those under 30
(odds ratio (OR) 5 2.49, 95% confidence interval (CI)
1.36–4.56). RFLP subtype a0 was not associated with
gender, but it was most prevalent among Black subjects,
followed by Whites, Hispanics, and American Indians.
Compared to Hispanics, Blacks had significantly higher
a0 prevalence (OR 5 2.3, 95% CI 1.37–3.85), and Whites
had nonsignificantly higher a0 prevalence. Compared to
Oklahoma City, the prevalence of RFLP type a0 was
significantly higher in San Francisco (OR 5 2.59, 95% CI
1.04–6.45) and Baltimore/Washington, DC (OR 5 2.56,
95% CI 1.06–6.21).
We then performed unadjusted analyses of subtypes
b4 and b5 combined since these were the next most
commonly observed HTLV-II RFLP subtypes and be-
cause they had previously been shown to be common
among American Indians (Switzer et al., 1995). Once
again there was no statistically significant association
Study Subjects in the Five U.S. Blood Centers
eles
66)
(%)
San Francisco
(n 5 70)
Number (%)
Oklahoma City
(n 5 35)
Number (%)
Total
(n 5 493)
Number (%)
.5) 5 (7.1) 7 (20.0) 48 (9.7)
.8) 19 (27.1) 10 (28.6) 176 (35.7)
.1) 26 (37.1) 12 (34.3) 161 (32.7)
.6) 20 (28.6) 6 (17.1) 108 (21.9)
.0) 14 (20.0) 16 (45.7) 138 (28.0)
.1) 56 (80.0) 19 (54.3) 355 (72.0)
.9) 40 (57.1) 9 (25.7) 135 (27.4)
.7) 20 (28.6) 14 (40.0) 199 (40.4)
.5) 8 (11.4) 0 (0) 122 (24.8)
4) 1 (1.4) 11 (31.4) 21 (4.3)
5) 1 (1.4) 1 (2.9) 16 (3.2)ABLE 1
fected
os Ang
(n 5 2
umber
28 (10
98 (36
88 (33
52 (19
77 (29
189 (71
61 (22
71 (26
113 (42
9 (3.
12 (4.with gender, and although subtypes b4/b5 appeared to
be more common among donors under 30, the age
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92 LIU ET AL.association was not statistically significant (P . 0.05,
able 3). Other variables showed associations with
4/b5 that were generally the inverse of the above-noted
0 associations. Subtypes b4/b5 were most common
mong American Indian donors, (OR 5 6.19, 95% CI
.27–16.91 versus Black donors) and in persons donating
lood in Oklahoma City (OR 5 6.43, 95% CI 2.17–19.06,
ompared to Washington, DC/Baltimore).
Multivariable logistic regression modeling was per-
ormed to control for potential confounding by one de-
ographic variable on another (Tables 2 and 3). After
djustment, persons who were 30 years or older or of
lack race/ethnicity remained more likely to have HTLV-II
ubtype a0 than other subtypes. The associations be-
ween subtype a0 and geographic location became sta-
istically nonsignificant after adjustment, probably due to
ifferent age and race/ethnicity compositions of the cen-
ers. The subtype b4/b5 multivariable analysis yielded
esults similar to the unadjusted analysis, with Black
TLV-II-infected subjects being least likely to have these
ubtypes while American Indian (OR 5 3.77) and Other
OR 5 4.22) race/ethnicity subjects were most likely to
ave subtypes b4/b5. Oklahoma City remained more
ikely to have persons with b4/b5 subtypes (OR 5 3.57,
5% CI 1.08–11.84), while the association with Los Ange-
T
Unadjusted and Multivariable Logistic Regression Ana
and Various Demo
Number (%)
a0
(n 5 358)
Non-a0
(n 5 135)
Age
,30 26 (54.2) 22 (45.8)
$30 332 (74.6) 113 (25.4)
Gender
Male 97 (70.3) 41 (29.7)
Female 261 (73.5) 94 (26.5)
Race
Hispanic 80 (65.6) 42 (34.4)
Black 162 (81.4) 37 (18.6)
White 96 (71.1) 39 (28.9)
American Indian 11 (52.4) 10 (47.6)
Other 9 (56.3) 7 (43.8)
Geographic location
Oklahoma City 22 (62.9) 13 (37.1)
Washington, DC/Baltimore 65 (81.3) 15 (18.8)
Detroit 32 (76.2) 10 (23.8)
Los Angeles 182 (68.4) 84 (31.6)
San Francisco 57 (81.4) 13 (18.6)
a Associations that were statistically significant at the P , 0.05 leves was no longer statistically significant after adjust-
ent.
(
1emographic associations with HTLV-II subtypes—
omen only
We next analyzed the 355 women separately because
hey represented 72% of all subjects and because they
ere more likely to have acquired HTLV-II by maternal to
hild or sexual infection than by IDU. Compared to the
nalysis of all subjects, similar but somewhat stronger
ssociations between HTLV-II RFLP subtype a0 and de-
ographics were present in the women. In an unad-
usted analysis, women 30 years and older (OR 5 2.77,
5% CI 1.35–5.69) and Black women (OR 2.62, 95% CI
.43–4.82 versus Hispanic) were more likely to be sub-
ype a0. There was a stronger association between sub-
ype a0 and San Francisco (OR 2.54, 95% CI 1.17–5.53
ersus Los Angeles) when cities were considered indi-
idually or Washington, DC/Baltimore, Detroit, and San
rancisco (OR 5 2.26, 95% CI 1.35–3.78 versus Los An-
eles and Oklahoma City) when groups of cities were
xamined. After multivariable adjustment, age 30 years
nd older (OR 2.32, 95% CI 1.08–5.02), Black race (OR
.15, 95% CI 1.05–4.41), and San Francisco location (OR
.46, 95% CI 1.09–5.57) remained significantly associated
ith HTLV-II RFLP type a0.
In the female-only unadjusted analysis, HTLV-II RFLP
ubtypes b4 and b5 were associated with Hispanic
f the Association between HTLV-II RFLP Subtype a0
c Characteristics
Unadjusted analysisa Multivariable analysisa
Odds ratio 95% CI Odds ratio 95% CI
1.00 — 1.00 —
2.49 (1.36–4.56) 2.12 (1.13–3.99)
1.00 — 1.00 —
1.17 (0.76–1.81) 1.04 (0.66–1.64)
1.00 — 1.00 —
2.30 (1.37–3.85) 2.00 (1.1–3.65)
1.29 (0.76–2.19) 1.12 (0.63–2.0)
0.58 (0.23–1.47) 0.64 (0.22–1.81)
0.68 (0.24–1.94) 0.74 (0.25–2.19)
1.00 — 1.00 —
2.56 (1.06–6.21) 1.46 (0.54–3.96)
1.89 (0.71–5.07) 1.22 (0.41–3.58)
1.28 (0.62–2.66) 1.14 (0.49–2.67)
2.59 (1.04–6.45) 2.09 (0.76–5.74)
iven in boldface type.ABLE 2
lysis o
graphiOR 5 2.44, 95% CI 1.1–5.37), White (OR 5 2.50, 95% CI
.18–5.30), and Other race/ethnicity (OR 5 5.19, 95% CI
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93HTLV-II RFLP SUBTYPES IN THE UNITED STATES1.16–23.23 versus Black race/ethnicity); the proportion of
subtypes b4/b5 was elevated among American Indian
women but statistical significance was not achieved,
probably due to small numbers. Subtypes b4/b5 were
associated with Oklahoma City (OR 5 4.14, 95% CI 1.05–
6.30) and Los Angeles (OR 5 2.73, 95% CI 1.02–7.29).
ultivariable modeling was limited by small numbers in
ome strata. Although ORs were increased for several
on-Black race/ethnicity groups, only White race/ethnic-
ty (OR 5 2.49, 95% CI 1.10–5.67) was significantly asso-
iated with subtypes b4/b5, and the increased OR of 2.77
ound for Oklahoma City had confidence intervals that
ncluded unity.
DISCUSSION
This study has conclusively demonstrated that HTLV-II
FLP subtypes are associated with specific population
ubgroups defined by demographic and geographic
haracteristics. Such associations may be useful in un-
aveling the transmission dynamics of HTLV-II in the
nited States over the past 50 to 100 years, and perhaps
FIG. 1. Prevalence of HTLV-II RFLP subtypes, by age, race, and geo
as HTLV-II RFLP subtype a0, and the right-hand panels show the proparlier. Compared to all other HTLV-II RFLP subtypes,
ubtype a0 was independently associated with thoseover the age of 30 and with Black race in all subjects. It
was most prevalent in San Francisco and Washington,
DC/Baltimore and remained independently associated
with San Francisco when only women were considered.
Conversely, HTLV-II RFLP subtypes b4 and b5 were as-
sociated with American Indian ethnicity and with location
in Oklahoma City. There were no sex differences in
HTLV-II subtype. These data suggest that there are at
least two foci of HTLV-II in the United States: a moderate
older a0 epidemic of unknown source among older and
Black persons and with broad geographic distribution;
and a transmission focus of HTLV-II subtypes b4/b5
probably derived from American Indians and centered in
Oklahoma and perhaps other locations not covered by
this study.
The predominant hypothesis regarding HTLV-II trans-
mission dynamics is that infection spread from Native
Americans to IDUs and then to their sexual partners and
other population groups (Salemi et al., 1999b). We did
find evidence for associations of HTLV-II RFLP subtypes
b4 and b5 with American Indian race and donation in
location. The left-hand panels show the proportion of samples typed
of samples typed as HTLV-II RFLP subtypes b4 or b5.Oklahoma City, an area with many Indian reservations.
However, it is surprising that we have replicated our
el are g
94 LIU ET AL.previous finding that HTLV-II subtype a0, the most com-
mon HTLV-II subtype in the United States, was associ-
ated with older age and with Black race and was least
common among Native Americans (Murphy et al., 1998).
These data suggest either that HTLV-II RFLP subtype a0
had an endemic focus among Black persons that was
subsequently amplified by injected drug use transmis-
sion or that injected drug-use transmission of this
HTLV-II subtype from an unknown source occurred pref-
erentially among Black individuals.
We also observed a higher proportion of HTLV-II sub-
type a0 among those ages 30 years and older. In con-
trast, there was no age association with HTLV-II sub-
types b4 and b5. We believe that the age association
does not mean that age per se determines subtype, but
rather that age is a surrogate for calendar time. Succes-
sive age cohorts of blood donors had exposure to the
specific HTLV-II subtype that was most common during
their period of parenteral and sexual risk activity. A peak
of HTLV-II seroprevalence among blood donors ages 30
to 49 has been interpreted as evidence of an age-cohort
effect for HTLV-II (Murphy et al., 1999b). The current data
support the concept that the moderate epidemic of
HTLV-II in the 1960s and 1970s in donors who are now
over 30 consisted predominantly of subtype a0. Age was
not independently associated with HTLV-II RFLP sub-
types b4 and b5, suggesting that low-level transmission
of these subtypes in certain populations has not
T
Unadjusted and Multivariable Logistic Regression Analysis of th
and Various Demo
Number (%)
b4/b5
(n 5 83)
Non-b4/b5
(n 5 410)
Age
,30 10 (20.8) 38 (79.2)
$30 73 (16.4) 372 (83.6)
Gender
Male 28 (20.3) 110 (79.7)
Female 55 (15.5) 300 (84.5)
Race
Black 18 (9) 181 (91)
Hispanic 24 (19.7) 98 (80.3)
White 28 (20.7) 107 (79.3)
Indian 8 (38.1) 13 (61.9)
Other 5 (31.3) 11 (68.8)
Geographic location
Washington, DC/Baltimore 6 (7.5) 74 (92.5)
Oklahoma City 12 (34.3) 23 (65.7)
Detroit 8 (19) 34 (81)
Los Angeles 48 (18) 218 (82)
San Francisco 9 (12.9) 61 (87.1)
a Associations that were statistically significant at the P , 0.05 levchanged substantially over time.
Geographic variations in the proportion of subtype a0among the HTLV-II-infected donors was confounded to
some degree by differences in the age and racial/ethnic
composition of donors from the five cities. Thus, high
proportions of subtype a0 in Baltimore/Washington, DC
and San Francisco were no longer significantly elevated
after age and race/ethnicity were adjusted for in the
logistic regression analysis. However, when the analysis
was restricted to female subjects, San Francisco per-
sisted in being the city with the highest proportion of
subtype a0 even after adjustment for age and race/
ethnicity. Taken together with other studies suggesting
an uneven distribution of HTLV-II infection among IDUs
(Briggs et al., 1995), this finding is consistent with San
Francisco and perhaps Washington, DC/Baltimore being
foci of a moderate HTLV-II subtype a0 epidemic among
IDUs and their sexual partners. In contrast, HTLV-II sub-
types b4 and b5 were independently associated with
donation in Oklahoma City and were least frequent in
San Francisco and Washington, DC/Baltimore.
The fact that we observed no difference in HTLV-II
subtype between males and females is consistent with
the hypothesis that there is no difference between the
various subtypes in their efficiency of sexual transmis-
sion. Although it has been recognized that HTLV-II and
HTLV-I are transmitted more easily from male to female
than vice versa during sexual intercourse, resulting in
higher overall HTLV-II seroprevalence among women
(Murphy et al., 1989, 1999b; Kaplan et al., 1996), sexual
ociation between HTLV-II RFLP Subtypes b4 and b5 Combined
c Characteristics
Unadjusted analysisa Multivariable analysisa
dds ratio 95% CI Odds ratio 95% CI
1.00 — 1.00 —
0.75 (0.36–1.56) 0.99 (0.45–2.17)
1.00 — 1.00 —
0.72 (0.44–1.19) 0.86 (0.51–1.47)
1.00 — 1.00 —
2.46 (1.27–4.76) 2.48 (1.16–5.31)
2.63 (1.39–4.98) 2.63 (1.33–5.20)
6.19 (2.27–16.91) 3.77 (1.23–11.57)
4.57 (1.43–14.62) 4.22 (1.25–14.27)
1.00 — 1.00 —
6.43 (2.17–19.06) 3.57 (1.08–11.84)
2.90 (0.93–9.01) 2.24 (0.70–7.19)
2.72 (1.12–6.60) 1.53 (0.57–4.06)
1.82 (0.61–5.4) 1.06 (0.33–3.35)
iven in boldface type.ABLE 3
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particular HTLV-II subtypes. In contrast to our previous
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95HTLV-II RFLP SUBTYPES IN THE UNITED STATESstudy of U.S. blood donors, White race was not associ-
ated with HTLV-II subtype a0 (Murphy et al., 1998). The
revious study was limited to a subset of “low-risk”
onors who repeatedly denied IDU, sex with an IDU, or a
istory of receiving a blood transfusion. Thus it may have
elected donors with occult sexual acquisition of HTLV-
I, who in turn may be more likely to be White.
The strengths of the current study include the large
umber of subjects studied, the use of a uniform sam-
ling frame of blood donors in five United States cities
nstead of samples of convenience, and the availability of
emographic data collected in a systematic fashion.
eaknesses of the study include the relatively small
umber of donors ages 30 years and younger and of
merican Indian race, which limited its power to detect
ifferences in these subgroups. Logistic regression
odeling was also limited by relatively small sample
izes in certain demographic and geographic strata, par-
icularly for the b4/b5 analysis in women. Racial and
thnic classification was by self-report and may not re-
lect actual genetic heritage. Future studies may wish to
se recently described genetic markers for various hu-
an populations (Jin et al., 1999). Finally RFLP subtyping,
although shown previously to correlate well with geno-
types (Switzer et al., 1995; Murphy et al., 1998), is poten-
tially less accurate and does not allow the construction
of phylogenetic trees. Nevertheless it is useful in large
studies such as this when proviral sequencing would be
impractical.
In conclusion, these data are consistent with the hy-
pothesis that there are at least two epidemic foci of
HTLV-II in the United States. Most important was a mod-
erate epidemic of HTLV-II RFLP subtype a0 that probably
affected predominantly Black blood donors in the United
States during the 1960s and 1970s. Whether the concen-
tration of subtype a0 among Black donors represents
amplification of HTLV-II from an outside source or the
existence of a small focus of endemic HTLV-II among
Black Americans remains to be determined. In addition
there has been an ongoing transmission focus of HTLV-II
subtype b4/b5, perhaps derived from American Indians
and centered in Oklahoma or other states with large
Indian populations. Molecular epidemiological studies of
HTLV-II in a larger sample of United States blood donors
including a broader range of geographic areas will be
important to confirm these results. In addition, foci of
endemic HTLV-II subtype a0 should be sought in other
non-IDU populations of Native American and Black per-
sons.
MATERIALS AND METHODS
Subjects and samples
We selected 493 HTLV-II seropositive blood donors
from five U.S. blood centers (Baltimore/Washington, DC,
Detroit, Oklahoma City, San Francisco, and Los Angeles)participating in the Retrovirus Epidemiology Donor Study
(REDS). We included all available samples from subjects
found to be HTLV seropositive at the time of blood do-
nation in 1988 through 1992 and who were typed as
HTLV-II by either polymerase chain reaction (PCR) or
type-specific serologic assays. Ninety-seven subjects in
this analysis had been included in a previous report
(Murphy et al., 1998). Most subjects had frozen periph-
eral blood mononuclear cells (PBMC) samples due to
their subsequent enrollment in a prospective cohort
study of HTLV-II-infected persons, while the minority who
did not enroll in the cohort had frozen whole blood
specimens prepared from the initial blood donation. De-
mographic data were obtained from the REDS database.
The study protocol was approved by the University of
California San Francisco Committee on Human Re-
search.
Laboratory methods
From each PBMC specimen, 1.5 million cells were
washed twice with PCR solution A to remove dimethyl
sulfoxide and processed into a white blood cell pellet.
Aliquots of 0.5 ml frozen whole blood were processed
into white cell pellets according to the method of Lee et
al. (1998). Leukocyte pellets were then treated with a
whole blood specimen preparation kit containing pro-
teinase K (Roche Molecular Systems, Branchburg, NJ) to
yield 0.2-ml cell lysates.
Nested PCR of the HTLV-II long terminal repeat region
was then performed on lysed samples using the method
of Switzer et al. (1995) with some modifications. Initial
primers BSQF6 and BSDR3 amplified a 672-bp product.
The initial PCR mixture consisted of 0.2 mM dNTP, 13
PCR buffer II (Perkin–Elmer–Cetus, Gaithersburg, MD),
each primer at 10 pmol, 2 units of Taq polymerase (Per-
kin–Elmer-Cetus), and 0.44 mg Taqstart antibody (Clon-
tech, Palo Alto, CA), 12.5 ml DNA template lysate, and
water in a total volume of 50 ml. No magnesium was
added because of preexisting magnesium in the lysis
buffer. The nested PCR mixture consisted of the same
reagents plus MgCl2 (PE Biosystems, Foster City, CA) at
2 mM final concentration. A 1.5-ml volume of first PCR
product was added to the nested PCR mixture for a total
volume of 50 ml.
A touchdown PCR protocol (decreasing annealing
temperature with progressive cycles) was used on a
Perkin–Elmer 9600 thermocycler (Don et al., 1991). Fol-
lowing denaturation at 94°C for 3 min, the reaction mix-
ture was cycled 35 times under the following conditions.
The first 14 cycles consisted of denaturation at 94°C for
30 s; annealing at 63 to 56°C (in decrements of 0.5°C per
cycle) for 30 s; and polymerization at 72°C for 30 s. The
remaining 20 cycles consisted of denaturation at 94°C
for 1 min; annealing at 55°C for 1 min; and polymeriza-
tion at 72°C for 1 min. Physical separation was main-
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96 LIU ET AL.tained between the sample preparation and post-PCR
manipulations. The presence of a PCR product of the
expected size was assessed by electrophoresis on a 2%
agarose gel with ethidium bromide.
RFLP analysis was performed on all specimens with
positive PCR results using four, five, or all of the following
enzymes: XhoI, AvaII, SauI (also called AocI) (Roche
olecular Biochemicals, Indianapolis, IN), BanII, SacII
Promega Corp., Madison, WI), and Eco47III (Fisher Sci-
ntific, Pittsburgh, PA). HTLV-II subtypes were deter-
ined by RFLP pattern according to Switzer et al. (1995).
he nested PCR products were not purified prior to RFLP.
eaction conditions included 2.5–5 ml of nested PCR
products, 5–10 units of enzyme plus 103 enzyme-spe-
cific buffers provided by the manufacturers, at a final
concentration of 13. Incubation was for 2 h at 37°C, and
reaction products were visualized on 2% agarose gels
with ethidium bromide.
Statistical methods
Statistical analyses were performed using Statistical
Analysis Software version 6.12 (SAS, Cary, NC). Correla-
tions between HTLV-II RFLP subtype and demographic
data were analyzed first in an unadjusted fashion by
constructing contingency tables and conducting x2 tests.
Unadjusted odds ratios and 95% confidence intervals
were calculated using the SAS Proc Logistic procedure,
with RFLP subtype as the dependent variable and each
demographic variable as the independent variable of
interest. Multivariable models were also constructed by
entering all demographic independent variables at the
same time.
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